A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation

S. Cascinu, R. Berardi, S. Salvagni, G. D. Beretta, V. Catalano, F. Pucci, A. Sobrero, P. Tagliaferri, R. Labianca, M. Scartozzi, F. Crocicchio, E. Mari, A. Ardizzoni

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation'. Together they form a unique fingerprint.

Medicine & Life Sciences